Immunotherapy: A sharp curve turn at the corner of targeted therapy in the treatment of biliary tract cancers Review


Authors: Al Mahmasani, L.; Harding, J. J.; Abou-Alfa, G.
Review Title: Immunotherapy: A sharp curve turn at the corner of targeted therapy in the treatment of biliary tract cancers
Keywords: cancer survival; overall survival; genetics; review; cancer recurrence; cisplatin; fluorouracil; cancer combination chemotherapy; gemcitabine; cancer adjuvant therapy; cancer radiotherapy; cancer staging; gene overexpression; cancer immunotherapy; enzyme inhibition; epidermal growth factor receptor 2; practice guideline; irinotecan; immunology; immunotherapy; cancer vaccine; folinic acid; chimeric antigen receptor; targeted therapy; bile duct carcinoma; cholangiocarcinoma; oxaliplatin; gallbladder cancer; b raf kinase; biliary tract cancer; biliary tract cancers; biliary tract neoplasms; biliary tract tumor; personalized medicine; perioperative care; recurrence free survival; clinical trial (topic); molecularly targeted therapy; isocitrate dehydrogenase 1; molecular targeted therapy; second-line treatment; fibroblast growth factor receptor; procedures; cytotoxic chemotherapy; immune checkpoint inhibitor; immunocytotoxicity; nivolumab; lenvatinib; humans; human; precision medicine; pembrolizumab; durvalumab; immune checkpoint inhibitors; ivosidenib; chimeric antigen receptor natural killer cell immunotherapy; pemigatinib; mouse double minute 2 homolog; futibatinib; adagrasib; gunagratinib
Journal Title: Hematology/Oncology Clinics of North America
Volume: 38
Issue: 3
ISSN: 0889-8588
Publisher: Elsevier Inc.  
Date Published: 2024-06-01
Start Page: 643
End Page: 657
Language: English
DOI: 10.1016/j.hoc.2024.01.005
PUBMED: 38423933
PROVIDER: scopus
DOI/URL:
Notes: Review -- MSK corresponding author is Ghassan Abou-Alfa -- Issue titled "Malignancies of the Upper Gastrointestinal Tract" (ISBN: 978-0-443-29596-6) -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. James Joseph Harding
    250 Harding
  2. Ghassan Abou-Alfa
    568 Abou-Alfa